In June 2009, the eighth annual ILSI* (Israel Life Science Industry) Biomed conference was held in Tel Aviv. ILSI-Biomed is a young yet "fast growing" and keyed-up conference, and this year was the most successful and probably the most fruitful yet.
According to CBDM.T®, the market and business intelligence company, the vaccine market is a huge and growing market valued at €16 billion in 2008 with an annual growth of about 15 to 18%. The vaccine market could account for more than €25 billion by 2012.
According to CBDMT®, the market and business intelligence company, contract biomanufacturing is a significant market estimated at €2.3 billion this year with an annual growth of about 10 to 15%. Pharmaceutical biomanufacturing could account for more than 20% of the global contract manufacturing market in 2012.
According to CBDM.T®, the market and business intelligence company, the biofuel market is estimated at €33 billion with a double digit annual growth. The market consists of approximately 85% bioethanol and 15% biodiesel. Bioethanol is produced and consumed mainly in Brazil and North America. On the other hand, Europe is the world leader in biodiesel production and this fuel represents about ¾ of the European biofuels market.
According to CBDM.T®, The market and business intelligence company, the enzyme market is significant and estimated at €3.4 billion with an annual growth of about 6.5 to 10%. Enzymes are sold in many different industry segments. These segments are Detergents, Food, Feed, Technical, Pharmaceutical, Microorganisms and Biofuels.